Skip to main content

Advertisement

SpringerLink
Log in

Arterial and venous thrombosis in patients with von Willebrand’s disease: A critical review of the literature

  • Case Reports and Reviews
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

All patients with von Willebrand’s disease (vWD) who showed an arterial or venous thrombosis and were reported in the literature have been evaluated. 11 patients had arterial thrombosis while 19 had venous thrombosis for a total of 30 cases. 9 out the 11 cases with arterial thrombosis had myocardial infarction. Two had cerebral thrombosis. Associated risk factors for arterial thrombosis were available only for three patients who showed, respectively, smoking and dyslipidemia (2 cases) and smoking and intravenous desmopressin infusion (1 case). The majority of patients with venous thrombosis showed DVT with or without PE. Four patients presented with apparently isolated PE. In two instances thrombosis occurred in unusual sites (central retinal vein and portal vein, respectively). Several associated risk factors were present, mainly: infusion of FVIII or FVIII + vWF concentrates in 7 cases; surgery in 8 cases, pregnancy in 1, desmopressin infusion in 1, variable coagulation defects or polymorphisms in 5. More than one of these associated conditions were present in a few patients. The majority of vWD patients who showed thrombotic phenomena were type I patient, but in 6 cases were also type 3. The type of defect was not reported in 6 patients. As a conclusion of this review it seems safe to assume that both arterial and venous thrombosis appear rare in vWD. This is confirmed by the fact that arterial or venous thrombosis appears slightly more frequent in hemophilia A and B.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Rosendaal FR, Briet E, Stibbe J, et al. Haemophilia protects against ischaemic heart disease: a study of risk factors. Br J Haematol 1990;75:525–530.

    Article  CAS  PubMed  Google Scholar 

  2. Martinelli I. Von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Sem Hematol 2005;42:49–55.

    Article  CAS  Google Scholar 

  3. Girolami A, Randi ML, Ruzzon E, Zanon E, Girolami B. Myocardial infarction, other arterial thrombosis and invasive coronary procedures in haemophilia B patients: a critical evaluation of reported cases. J Thromb Thrombol 2005;20:43–46.

    Article  CAS  Google Scholar 

  4. Nowak-Gottl U, Escuriola C, Kurnik K, et al. Haemophilia and thrombophilia. What do we learn about combined inheritance of both genetic variations? Hamostaseologie 2003;23:36–40.

    CAS  PubMed  Google Scholar 

  5. Van Dijk K, Van der Bom JG, Fischer K, Grobbee DE, Van den Berg HM. Do prothrombotic factors influence clinical phenotype of severe haemophilia? A review of the literature. Thromb Haemost 2004;92:305–310.

    PubMed  Google Scholar 

  6. Goodnough LT, Saito H, Ratnoff OD. Thrombosis or myocardial infarction in congenital clotting factor abnormalities and chronic thrombocytopenias: a report of 21 patients and a review of 50 previously reported cases. Medicine 1982;62:248–255.

    Google Scholar 

  7. Girolami A, Ruzzon E, Fabris F, Varvarikis C, Sartori R, Girolami B. Myocardial infarction and other arterial occlusions in haemophilia A patients: a cardiological evaluation of all 41 reported cases. Acta Haemat (in press).

  8. Girolami A, Randi ML, Ruzzon E, Zanon E, Girolami B. Myocardial infarction. J Thromb Thr 2005;20:43–46.

    Article  CAS  Google Scholar 

  9. Silwer J, Cronberg S, Nilsson IM. Occurrence of arteriosclerosis in von Willebrand’s disease. Acta Med Scand 1966;180:475–484.

    Article  CAS  PubMed  Google Scholar 

  10. Dulhoste MN, Bonnet J, Vergnes C, Choussat A, Bricaud H. Maladie de Willebrand at atherosclerose coronarienne. Arch Mal Coeur 1989;82:1875–1878.

    CAS  PubMed  Google Scholar 

  11. Franchini M, Veneri D. Are only haemophiliacs protected against ischemic heart disease? Thromb Haemost 2004;92:1455–1455.

    CAS  PubMed  Google Scholar 

  12. Grainge C, Nokes T. Cerebral arterial thrombosis in a young woman following vasopressin for von Willebrand’s disease. Thromb Haemost 2004;93:380–380.

    Google Scholar 

  13. Petäjä J, Rasi V, Myllyla G, Vahtera E, Hallman H. Familial hypofibrinolysis and venous thrombosis. Brit J Haematol 1989;71:393–398.

    Article  Google Scholar 

  14. Bowen D, Dasani H, Yung B, Bloom A. Deep venous thrombosis and pulmonary embolism in a patient with type III von Willebrand’s disease, protein C and antithrombin III deficiency. Brit J Haematol 1992;81:446–447.

    Article  CAS  Google Scholar 

  15. Makris M, Colvin B, Gupta V, Shields ML, Smith MP. Venous thrombosis following the use of intermediate purity FVIII concentrate to treat patients with von Willebrand’s disease. Thromb Haemost 2002;88:387–388.

    CAS  PubMed  Google Scholar 

  16. Mannucci PM. Venous thromboembolism in von Willebrand disease. Thromb Haemost 2002;88:378–379.

    CAS  PubMed  Google Scholar 

  17. Mannucci PM, Chediak J, Hanna W, et al. Treatment of von Willebrand disease with a high-purity factor VIII/von Willebrand factor concentrate: a prospective, multicenter study. Blood 2002;99:450–456.

    Article  CAS  PubMed  Google Scholar 

  18. Franchini M, Krampera M, Veneri D. Deep vein thrombosis after orthopedic surgery in a patient with type 1 von Willebrand disease and mutations in the MTHFR and beta-fibrinogen genes. Thromb Haemost 2003;90:963–996.

    CAS  PubMed  Google Scholar 

  19. Casonato A, Pontara E, Soldera C, Bertomoro A, Girolami A. (Unpublished observations).

  20. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995;345:152–155.

    Article  CAS  PubMed  Google Scholar 

  21. Federici AB, Mannucci PM, Fogato E, Ghidoni P, Matturri L. Autopsy findings in three patients with von Willebrand disease type IIB and type III: presence of atherosclerotic lesions without occlusive arterial thrombi. Thromb Haemost 1993;70:759–761.

    Google Scholar 

  22. Badimon L, Steele P, Badimon JJ, Bowie EJ, Fuster V. Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs. Arteriosclerosis 1985;5:366–370.

    Article  CAS  PubMed  Google Scholar 

  23. Fuster V, Lie JT, Badimon L, Rosemark JA, Badimon JJ, Bowie EJ. Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease. Arteriosclerosis 1985;5:67–73.

    Article  CAS  PubMed  Google Scholar 

  24. Bilora F, Boccioletti V, Zanon E, Petrobelli F, Girolami A. Hemophilia A, von Willebrand disease, and atherosclerosis of abdominal aorta and leg arteries: factor VIII and von Willebrand factor defects appear to protect abdominal aorta and leg arteries from atherosclerosis. Clin Appl Thromb Hemost 2001;7:311–313.

    Article  CAS  PubMed  Google Scholar 

  25. Bilora F, Dei Rossi C, Girolami B, et al. Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. Clin Appl Thromb Hemost 1999;5:232–235.

    Article  CAS  PubMed  Google Scholar 

  26. Srämek A, Reiber JHC, Gerrits WBJ, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis. Circulation 2004;104:762–767.

    Article  Google Scholar 

  27. Srämek A, Bucciarelli P, Federici AB, et al. Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis. Circulation 2004;109:740–744.

    Article  PubMed  Google Scholar 

  28. Girolami A, Cliffton E, Agostino D. Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid. Thromb Diath Haemorrh 1967;17:165–175.

    CAS  PubMed  Google Scholar 

  29. Korninger C, Niessner H, Lechner K. Impaired fibrinolytic response to DDAVP and venous occlusion in a sub-group of patients with von Willebrand’s disease. ThrombRes. 1982;23:365–374.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy

    A Girolami (Prof), F Tezza, M Scapin, S Vettore & A Casonato

  2. Dept of Medical and Surgical Sciences, Via Ospedale 105, Padua, Italy, 35128

    A Girolami (Prof)

Authors
  1. A Girolami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Tezza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Scapin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S Vettore
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Casonato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Girolami.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Girolami, A., Tezza, F., Scapin, M. et al. Arterial and venous thrombosis in patients with von Willebrand’s disease: A critical review of the literature. J Thromb Thrombolysis 21, 175–178 (2006). https://doi.org/10.1007/s11239-006-5732-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-006-5732-0

Key Words

Search

Navigation